Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/BF02850002.pdf
Reference24 articles.
1. Lindholm L, Ibsen H, Bolch-Johnsen K, et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.J Hypertens. 2002;20:1879–1886.
2. Yusuf S, Ostergren JB, Gerstein HC, et al. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.Circulation. 2005;112:48–53.
3. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial.Lancet. 2004;63:2022–2031.
4. Shiuchi T, Iwai M, Li HS, et al. Angiotensin II type 1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.Hypertension. 2004;43:1003–1010.
5. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems.Proc Natl Acad Sci USA. 1996;93:12490–12495.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of angiotensin II receptor blockers on the course of the disease in patients with stable ischemic heart disease;Complex Issues of Cardiovascular Diseases;2022-03-18
2. Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocyte;Journal of Molecular Endocrinology;2022-03
3. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes?;Pharmacology & Therapeutics;2021-10
4. Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension;Cardiovascular Diabetology;2021-03-24
5. Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study;Transplantation Direct;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3